Navigation Links
US Dermatophytic Onychomycosis Market Discussed by GlobalData in Topical Report Now Available at MarketPublishers.com
Date:7/17/2013

py costs, treatment usage patterns, etc. The study contains a comprehensive pipeline analysis, evaluates the competitive environment, and presents details on the top companies operating in the market. The report examines major market drivers and restraints, outlines the market opportunities and challenges, characterizes prevailing development trends, and moreover, sheds light on the possible path of the market development through 2022.

Report Scope:

  •     Comprehensive overview of DO (epidemiology, general symptoms, disease treatment recommendations, etc.).
  •     All-round analysis of the US DO market.
  •     Historical and present data on the market performance.
  •     Description of the competitive scenario.
  •     Vital information on the major market opportunities.
  •     Clinical pipeline assessment.
  •     Profiles of the leading market players.
  •     Discussion of the important industry issues.
  •     Examination of the factors driving and restraining the market development.
  •     Detailed future market forecast up to 2022.

More research studies by the publisher can be found at GlobalData page.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10937702.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
6. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
7. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
8. GeneLink Marketing Efforts Poised to Show Results
9. Animal Biotechnology - Technologies, Markets and Companies
10. Gene Therapy - Technologies, Markets and Companies
11. Biomarkers - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Baltimore, MD (PRWEB) November 24, 2014 ... recruiting underrepresented patient populations into clinical trials at ... Maryland. , “Continental was created with the ... trials play a fundamental role in medical advances," ... the Tuskegee syphilis experiment to the immortal cell ...
(Date:11/24/2014)... November 24, 2014 Senior Vice ... for dynamic leadership skills, business acumen ... medical information products and services, congratulates Diane Bartoli ... Reference and Workflow, Elsevier Clinical Solutions, for being recognized ... ® Awards issue of Profiles in Diversity ...
(Date:11/22/2014)... (PRWEB) November 21, 2014 Prominent ... investors will gather on December 3rd at Genetic ... Conferences series. GeneticRx will take place at the ... School and will discuss the present and future ... exon skipping, and gene editing—as well as the ...
(Date:11/22/2014)... The “Chiral Chromatography Columns Market ... (Metal, Glass, Plastic), by Application [GC, LC (HPLC, ... to 2018” analyses and studies the major market ... Europe, Asia, and Rest of the World. , ... spread through 135 pages and in-depth TOC on ...
Breaking Biology Technology:At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5
... Pa., April 12, 2011 Morphotek®, Inc., a subsidiary ... received a grant of approximately $947,000 from the United ... development of therapeutic monoclonal antibodies (mAbs) capable of neutralizing ... project is part of a U.S. defense initiative to ...
... EMC Corporation (NYSE: EMC ), the world ... Medical Research Institute , which ranks among the top four ... and among the top 25 organizations worldwide for its research ... as the primary storage platform for its wide range ...
... 12, 2011 Sanford Rose Associates - Charleston, ... healthcare information technology, has promoted Bonnie R. Siegel ... Practice. Health information technology continues to ... trillion global healthcare marketplace. Bonnie will continue to ...
Cached Biology Technology:Morphotek Receives Grant to Support Development of Therapeutic Antibodies against Biowarfare Agents 2Morphotek Receives Grant to Support Development of Therapeutic Antibodies against Biowarfare Agents 3Sanford-Burnham Turns Big Data Into Scientific Breakthroughs With EMC Isilon 2Sanford-Burnham Turns Big Data Into Scientific Breakthroughs With EMC Isilon 3Sanford Rose Associates - Charleston Promotes Bonnie Siegel to Partner 2
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
(Date:11/7/2014)... associate professor, biomedical engineering, in the Grove School ... York, have identified a molecule that could lead ... aggressive forms of breast cancer. , Triple negative ... owing to aggressive proliferation and metastasis and a ... team, discovered the overexpression of intercellular adhesion molecule-1 ...
(Date:11/6/2014)... is an asset for a predator. Except when that predator ... tiger beetle, relative to its size, is the fastest creature ... body lengths per second (at about five miles per hour). ... take the sprinting gold from the tiger beetle, a person ... The tiger beetle has a problem. At peak speeds, everything ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3The tiger beetle: Too fast to see 2
... The global fight against the tuberculosis epidemic receives a ... Group (CNBG) announce that they have reached final agreement ... between the leading non-profit developer of TB vaccine candidates ... commitment by both to engage and strengthen the role ...
... Representatives of a giant tortoise species that had apparently ... ago must be alive today, if in very small numbers. ... Biology, a Cell Press publication, have come to this ... Chelonoidis elephantopus in the DNA of their hybrid ...
... WEST LAFAYETTE, Ind. - Modified probiotics, the beneficial ... one day decrease the risk of Listeria ... Purdue University research. Arun Bhunia, a professor of ... and Ok Kyung Koo, a former Purdue doctoral student, ...
Cached Biology News:Aeras and CNBG sign agreement on tuberculosis vaccine R&D 2'Extinct' for 150 years, an iconic Galpagos giant tortoise species lives 2Pill some day may prevent serious foodborne illness, scientist says 2
7G10 anti-Fasciclin III...
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
Rabbit polyclonal to ZA20D3 ( Abpromise for all tested applications). entrezGeneID: 54469 SwissProtID: Q6FIF0...
... for all tested applications). ... from within residues 1 - 100 of Mouse ... proprietary) (Peptide available as ... 5453 Swiss Protein ID: ...
Biology Products: